Rosol Michael Stanley 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jan 18, 2022
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Common Stock
2022-01-14+7,728→ 14,575 total
Holdings
- 6,816(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Stock issued under the Amended and Restated 2014 Stock Incentive Plan in lieu of cash bonus, as elected by the Reporting Person.